Summary
Mitochondrial diseases are a heterogeneous group of disorders caused by mutations in both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA). Mitochondrial disease leads to impaired respiratory chain function and reduced ATP production. The aim of this study was to compare disturbances in mitochondrial function by measuring ATP synthesis in fibroblasts derived from patients with nDNA and mtDNA defects. Skin fibroblasts derived from 22 patients with either nDNA-related disorders (n = 8) or mtDNA-related disorders (n = 14) were analysed. ATP synthesis was markedly decreased in fibroblasts derived from patients with nDNA-related disorders but only variably so in patients with mtDNA mutations. In fibroblasts with the MELAS 3243A > G mutation, ATP synthesis correlated with mutant load. We believe that the observed differences in ATP production between cell lines derived from patients with nDNA-related disorders and mtDNA-related disorders may help in the assessment of patients with undiagnosed mitochondrial disease. The clinical comparisons observed in patients with nDNA- and mtDNA-related disorders may be explained by differences in the disturbance of ATP synthesis measured in the two conditions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Antonicka H, Floryk D, Klement P, et al (1999) Defective kinetics of cytochrome c oxidase and alteration of mitochondrial membrane potential in fibroblasts and cytoplasmic hybrid cells with the mutation for myoclonus epilepsy with ragged-red fibres (‘MERRF’) at position 8344 nt. Biochem J 342: 537–544.
Carelli V, Baracca A, Barogi S, et al (2002) Biochemical–clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation. Arch Neurol 59: 264–270.
Chomyn A, Martinuzzi A, Yoneda M, et al (1992) MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 89: 4221–4225.
Houstek J, Klement P, Hermanska J, et al (1995) Altered properties of mitochondrial ATP-synthase in patients with a T → G mutation in the ATPase 6 (subunit a) gene at position 8993 of mtDNA. Biochim Biophys Acta 1271: 349–357.
Houstek J, Klement P, Hermanska J, et al (1999a) Complex approach to prenatal diagnosis of cytochrome c oxidase deficiencies. Prenat Diagn 19: 552–558.
Houstek J, Klement P, Floryk D, et al (1999b) A novel deficiency of mitochondrial ATPase of nuclear origin. Hum Mol Genet 8: 1967–1974.
James AM, Sheard PW, Wei YH, Murphy MP (1999) Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations. Eur J Biochem 259: 462–469.
King MP, Koga Y, Davidson M, Schon EA (1992) Defects in mitochondrial protein synthesis and respiratory chain activity segregate with tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol 12: 480–490.
Koga Y, Davidson M, Schon EA, King MP (1995) Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNALeu(UUR) gene. Muscle Nerve Suppl 3: S119–S123.
Manfredi G, Spinazzola A, Checcarelli N, Naini A (2001) Assay of mitochondrial ATP synthesis in animal cells. Methods Cell Biol 65: 133–145.
Manfredi G, Yang L, Gajewski CD, Mattiazzi M (2002) Measurement of ATP in mammalian cells. Methods 26: 317–326.
Marriage BJ, Clandinin MT, MacDonald IM, Glerum DM (2003) The use of lymphocytes to screen for oxidative phosphorylation disorders. Anal Biochem 313: 137–144.
Papadopoulou LC, Sue CM, Davidson M, et al (1999) Fatal infantile cardioencephalomyopathy with cytochrome c oxidase (COX) deficiency and mutations in SCO2, a human COX assembly gene. Nature Genetics 23: 333–337.
Pallotti F, Baracca A, Hernandez-Rosa E, et al (2004) Biochemical analysis of respiratory function in cybrid cell lines harboring mitochondrial DNA mutations. Biochem J 384: 287–293.
Porteous WK, James AM, Sheard PW, et al (1998) Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. Eur J Biochem 257: 192–201.
Sue CM, Crimmins DS, Quigley A, et al (1998) Detection of MELAS point mutation 3243 in blood, muscle and hair follicles. J Neurol Sci 161: 36–39.
Trounce I, Neill S, Wallace DC (1994) Cytoplasmic transfer of the mtDNA nt 8993 T → G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proc Natl Acad Sci USA 91: 8334–8338.
Zeviani M, Amati P, Bresolin N, et al (1991) Rapid detection of the A→G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged red fibers (MERRF). Am J Hum Genet 48: 203–211.
Zhu Z, Yao J, Johns T, et al (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genetics 20: 337–343.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Garry Brown
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Shepherd, R.K., Checcarelli, N., Naini, A. et al. Measurement of ATP production in mitochondrial disorders. J Inherit Metab Dis 29, 86–91 (2006). https://doi.org/10.1007/s10545-006-0148-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0148-8